- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Estrogen Receptor-negative Breast Cancer in Russian Federation
Total 212 results
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
Russian Academy of Medical SciencesCompletedEarly Triple Negative Breast CancerRussian Federation
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Russian Academy of Medical SciencesCompletedInduction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast CancerTriple Negative Breast CancerRussian Federation
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, A... and more
-
Eli Lilly and CompanyCompletedBreast Cancer | Neoplasm MetastasisRussian Federation
-
Tomsk National Research Medical Center of the Russian...RecruitingPrimary Breast CancerRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedBreast Cancer FemaleRussian Federation
-
Tomsk National Research Medical Center of the Russian...Enrolling by invitationBreast Cancer FemaleRussian Federation
-
Tomsk National Research Medical Center of the Russian...CompletedBreast Cancer FemaleRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala University; Institute of Bioorganic Chemistry, Russian Academy of SciencesCompletedPrimary Breast CancerRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedBreast Cancer FemaleRussian Federation
-
Blokhin's Russian Cancer Research CenterRecruitingBreast Cancer Stage IVRussian Federation
-
Center of Personalized Medicine, PirogovaI.M. Sechenov First Moscow State Medical University; Center for New Medical...UnknownBreast Cancer-specific SurvivalRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedFemale | HER2-positive Breast CancerRussian Federation
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Tatarstan Cancer CenterUnknownHereditary Breast CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...RecruitingOligometastatic Disease | HER2-positive Metastatic Breast CancerRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala University; KTH Royal Institute of TechnologyCompleted
-
Blokhin's Russian Cancer Research CenterRussian Society of Clinical OncologyCompletedMetastatic Disease | HR+/HER2- Breast Cancer | Аdvanced DiseaseRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedBreast Cancer | FemaleRussian Federation
-
KARANAHANRecruitingStage IV Breast CancerRussian Federation
-
BiocadCompletedHuman Epithelial Receptor (HER)-2 Positive Breast CancerUkraine, Russian Federation, Belarus, India
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedProstate Cancer | Breast Cancer FemaleRussian Federation
-
Blokhin's Russian Cancer Research CenterRecruitingBreast Cancer | Neoadjuvant Endocrine TherapyRussian Federation
-
N.N. Petrov National Medical Research Center of...UnknownBreast CancerRussian Federation
-
BiocadCompletedBreast CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...UnknownBreast CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...RecruitingRefusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNBRussian Federation
-
Eli Lilly and CompanyCompleted
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityRecruitingBreast Cancer | Prostate CancerRussian Federation
-
Moscow Clinical Scientific CenterRecruitingBreast Cancer | Solid Tumor | Gastrointestinal Cancer | Gynecological Malignancies | High-Risk Cancer | MyelosuppressionRussian Federation
-
Alpha Tau Medical LTD.TerminatedMetastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Distant Metastases.PathologyRussian Federation
-
BiocadActive, not recruiting
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingBreast Cancer | Postsurgical Acquired Absence of OrganRussian Federation
-
BiocadRecruitingBreast CancerRussian Federation
-
Moscow Clinical Scientific CenterNegovsky Reanimatology Research InstituteRecruiting
-
Moscow Clinical Scientific CenterRecruitingBreast Cancer | Pancreas CancerRussian Federation
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
-
Merrimack PharmaceuticalsCompletedHer2 Negative Breast Cancer PatientsUnited States, Spain, Canada, Germany, Russian Federation
-
OmicsWay Corp.Oncobox Ltd., Russia; Vitamed LLC, Russia; Republican Oncological Dispensary...Active, not recruitingHER2-positive Breast CancerUnited States, Russian Federation
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
Novartis PharmaceuticalsCompletedBreast CancerSpain, United Kingdom, Taiwan, Australia, Russian Federation, Germany, Korea, Republic of, Ireland, United States, Italy, Brazil, Czech Republic
-
Meabco A/SMeddoc; Norwegian University of Life SciencesCompletedMetastatic Breast Cancer | Stage IV Breast CancerThailand, Russian Federation
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
Achieve Life SciencesCompletedBreast CancerRussian Federation
-
Novartis PharmaceuticalsRecruiting
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
Meabco A/SMeddoc; Norwegian University of Life SciencesCompletedMetastatic Breast Cancer | Stage IV Breast CancerThailand, Russian Federation
-
Moscow Clinical Scientific CenterRecruitingGastric Cancer | Helicobacter Pylori Infection | Gastric AtrophyRussian Federation